Clinical Trials Directory

Trials / Completed

CompletedNCT01949779

TransForm™ Occlusion Balloon Catheter Registry

Status
Completed
Phase
Study type
Observational
Enrollment
81 (actual)
Sponsor
Stryker Neurovascular · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this registry is to collect real world data on the safety and performance of the TransForm™ Occlusion Balloon Catheter when used in current neurointerventional procedures

Detailed description

* This is a prospective, single-arm, non-randomized, multi-center, observational registry. * The expected duration for study enrollment is approximately 6 months-1 year. * Study participation for each subject will be completed upon removal of the guide catheter post-procedure. * Up to 140 subjects will be enrolled at up to 15 study sites. A given site will be allowed to enroll a maximum of 20 subjects. * Enrollment in the registry occurs after a signed Informed Consent Form has been obtained, and the index procedure starts.

Conditions

Interventions

TypeNameDescription
DEVICETransForm™ Occlusion Balloon CatheterTransForm™ Occlusion Balloon Catheter

Timeline

Start date
2013-12-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2013-09-25
Last updated
2019-09-06
Results posted
2019-08-19

Locations

7 sites across 2 countries: United States, Spain

Source: ClinicalTrials.gov record NCT01949779. Inclusion in this directory is not an endorsement.